The role of companion diagnostic tests in drug development and patient management for targeted therapy has become an area of intensive cancer research. Examples of recently approved targeted therapies that require companion diagnostic mutation testing include the selective BRAF inhibitor vemurafenib in malignant melanoma (BRAF V600 mutations).
Journal of Medical Diagnostic Methods is one of the top online publishing journals for research from the field of Companion Diagnostic Tests. The open access articles published in this scholarly journal are reviewed by at least two reviewers of the associated fields. The journal publishes original research articles, reviews, case reports, short communications, etc and emphasizes theoretical and experimental work. To ensure high quality articles, both editors and reviewers actively participate in the peer review process and help in completing the review process within 21 days. As an important educational platform the journal provides scientists and researchers access to the newest trends and research outlooks. Please browse through the list of peer-reviewed journals to find the scientific publication of your interest.
Last date updated on September, 2024